Back to mobile site

Goldman Sachs Reiterates Buy Rating on Ultragenyx Pharma (RARE)

July 10, 2025 6:01 AM EDT Send to a Friend
Goldman Sachs analyst Salveen Richter reiterated a Buy rating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login